Search

GlaxoSmithKline PLC

Closed

Sector Healthcare

1,322 0.04

Overview

Share price change

24h

Current

Min

1318

Max

1323

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+23.33 upside

Dividends

By Dow Jones

Next Earnings

5 Feb 2025

Next Dividend date

9 Jan 2025

Next Ex Dividend date

20 Feb 2025

News Sentiment

By Acuity

58%

42%

331 / 392 Healthcare

GlaxoSmithKline PLC Chart

Past performance is not a reliable indicator of future results.

Related News

15 Nov 2024, 10:28 UTC

Major Market Movers

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

30 Oct 2024, 11:44 UTC

Earnings

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness -- Update

30 Oct 2024, 07:50 UTC

Earnings

GSK Profit Rises on HIV, Cancer Treatments But Sales Slip on Weak U.S. Vaccine Demand

29 Oct 2024, 13:39 UTC

Acquisitions, Mergers, Takeovers

GSK Buys Lupus Treatment For Up To $850 Million From Chimagen Biosciences

15 Nov 2024, 13:08 UTC

Top News

Trump's RFK Pick Weighs on Vaccine Makers -- WSJ

15 Nov 2024, 10:34 UTC

Market Talk

Vaccine Sector Sell-Off Looks Overdone -- Market Talk

15 Nov 2024, 10:29 UTC

Hot Stocks

Stocks to Watch Friday: Tesla, Domino's, Palantir, Ulta -- WSJ

7 Nov 2024, 11:53 UTC

Top News
Earnings

Moderna Earnings Beat Estimates. But Its Future Still Looks Uncertain. -- Barrons.com

7 Nov 2024, 11:31 UTC

Earnings

Moderna Earnings Beat Estimates. But Its Future Still Looks Uncertain. -- Barrons.com

31 Oct 2024, 19:48 UTC

Top News

AstraZeneca Probe in China Adds to Concerns for Foreign Businesses -- Update

30 Oct 2024, 15:04 UTC

Market Talk
Earnings

GSK's 3Q Results Are a Mixed Bag -- Market Talk

30 Oct 2024, 08:22 UTC

Market Talk
Earnings

GSK's Vaccine Weakness Is a Major Concern -- Market Talk

30 Oct 2024, 07:18 UTC

Earnings

GSK Reiterates Guidance As HIV And Cancer Drug Demand Offset Vaccine Weakness -- MarketWatch

30 Oct 2024, 07:04 UTC

Earnings

GSK PLC Expects to deliver Around Middle of Existing Annual Guidance Ranges

30 Oct 2024, 07:03 UTC

Earnings

GSK PLC 3Q EPS 1.4p

30 Oct 2024, 07:02 UTC

Earnings

GSK PLC Had Seen 2024 Sales Growth of 7% to 9%

30 Oct 2024, 07:02 UTC

Earnings

GSK PLC Issues Dividend of 15p

30 Oct 2024, 07:01 UTC

Earnings

GSK PLC Had Seen 2024 Core Earnings Per Share Growth of 10% to 12%

30 Oct 2024, 07:01 UTC

Earnings

GSK PLC Had Seen 2024 Core Operating Pft Growth Between 11% and 13%

30 Oct 2024, 07:01 UTC

Earnings

GSK PLC Backs 2024 View

30 Oct 2024, 07:00 UTC

Earnings

Analysts Saw GSK PLC 3Q Net Pft GBP1.78B

30 Oct 2024, 07:00 UTC

Earnings

Analysts Saw GSK PLC 3Q Turnover GBP8.00B

30 Oct 2024, 07:00 UTC

Earnings

GSK PLC 3Q Loss/Shr 1.4p

30 Oct 2024, 07:00 UTC

Earnings

GSK PLC 3Q Turnover GBP8.01B

30 Oct 2024, 07:00 UTC

Earnings

GSK PLC 3Q Adj EPS 49.7p

30 Oct 2024, 07:00 UTC

Earnings

GSK PLC 3Q Pre-items, Pretax Pft GBP2.65B

30 Oct 2024, 07:00 UTC

Earnings

GSK PLC 3Q Pretax Pft GBP64M

30 Oct 2024, 07:00 UTC

Earnings

GSK PLC 3Q Oper Pft GBP189M

30 Oct 2024, 07:00 UTC

Earnings

GSK PLC 3Q Net Loss GBP58M

29 Oct 2024, 13:24 UTC

Acquisitions, Mergers, Takeovers

GSK Buys Lupus Treatment For Up To $850 Mln From Chimagen Biosciences

GlaxoSmithKline PLC Forecast

Price Target

By TipRanks

23.33% upside

12 Months Forecast

Average 1,628 GBX  23.33%

High 2,355 GBX

Low 1,350 GBX

Based on 12 Wall Street analysts offering 12 month price targets forGlaxoSmithKline PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

12 ratings

3

Buy

7

Hold

2

Sell

Sentiment

By Acuity

331 / 392 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

$